Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial study record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-24T14:58:15.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:32.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:43:11.000Z thumbnail image
  4. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the loaded study record content with a minimal header and footer, indicating access is blocked.
    Difference
    17%
    Check dated 2026-09-19T18:53:33.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The revision label was updated from v3.6.5 to v3.6.6, indicating a software update. There are no visible changes to study content or user-facing functionality.
    Difference
    0.0%
    Check dated 2026-08-29T19:09:30.000Z thumbnail image
  6. Check
    79 days ago
    Change Detected
    Summary
    The page now reflects an updated platform revision to v3.6.5, indicating an underlying system update; user-facing study information remains unchanged.
    Difference
    0.0%
    Check dated 2026-08-08T08:53:57.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.